Advancing Myopia Management Will Unlock Global MedTech Potential
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 18 Analysts
Published
16 Feb 25
Updated
07 Aug 25
AnalystConsensusTarget's Fair Value
€261.17
3.2% undervalued intrinsic discount07 Aug
€252.90
1Y
22.0%7D
-1.3%